title: Soft tissue and skeletal involvement in FIP1L1-PDGFR-alpha positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission.
authors.affiliation: Institute of Hematology and Medical Oncology L & A Seràgnoli, University of Bologna, Italy. acute@med.unibo.it
authors.forename: Michele
authors.initials: M
authors.lastname: Malagola
authors.forename: Giovanni
authors.initials: G
authors.lastname: Martinelli
authors.forename: Michela
authors.initials: M
authors.lastname: Rondoni
authors.forename: Emanuela
authors.initials: E
authors.lastname: Ottaviani
authors.forename: Pier Paolo
authors.initials: PP
authors.lastname: Piccaluga
authors.forename: Paolo
authors.initials: P
authors.lastname: Ricci
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Visani
authors.forename: Michele
authors.initials: M
authors.lastname: Baccarani
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D001853:Bone Marrow / Q000473:pathology; D002908:Chronic Disease; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000097:blood*; D016896:Treatment Outcome; D039221:mRNA Cleavage and Polyadenylation Factors / Q000097:blood*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; C479818:FIP1L1 protein, human; D010879:Piperazines; D011743:Pyrimidines; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; D020796:Receptor, Platelet-Derived Growth Factor alpha